OPEN

Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression

Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L. | Journal of Psychopharmacology | 16 January 2020

By OPEN|2020-03-02T19:14:18+02:0016 January 2020|Tags: D. Nutt, L. Demetriou, L. Mertens, L. Roseman, M. Wall, R. Carhart-Harris|

Ayahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkers.

Murphy-Beiner, A., & Soar, K. | Psychopharmacology | 11 January 2020

By OPEN|2020-03-12T16:35:49+02:0011 January 2020|Tags: K. Soar, Murphy-Beiner. A|

A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamine

Palamar, J. J., & Acosta, P. | Clinical and Experimental | 07 January 2020

By OPEN|2020-03-02T19:05:49+02:007 January 2020|Tags: J. Palamar, P. Acosta|

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

Halberstadt, A. L., Chatha, M., Klein, A. K., Wallach, J., & Brandt, S. D. | Neuropharmacology | 7 January 2020

By OPEN|2020-03-02T18:59:13+02:007 January 2020|Tags: A. Halberstadt, A. Klein, J. Wallach, M. Chatha, S. Brandt|

The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.

Goldberg, S. B., Pace, B. T., Nicholas, C. R., Raison, C. L., & Hutson, P. R. | Psychiatry Research | 2 January 2020

By OPEN|2020-04-02T11:49:35+02:002 January 2020|Tags: B. Pace, C. Nicholas, C. Raison, P. Hutson, S. Goldberg|

Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity.

Bershad, A. K., Preller, K. H., Lee, R., Keedy, S., Wren-Jarvis, J., Bremmer, M. P., & de Wit, H. | Biological Psychiatry: Cognitive Neuroscience and Neuroimaging | 20 December 2019

By OPEN|2020-04-02T11:41:54+02:0020 December 2019|Tags: A. Bershad, H. de Wit, J. Wren-Jarvis, K. Preller, M. Bremmer, R. Lee, S. Keedy|

Esketamine is approved in Europe for treating resistant major depressive disorder

Mahase, E. | BMJ | 20 December 2019

By OPEN|2020-02-24T20:01:57+02:0020 December 2019|Tags: E. Mahase|

Lysergic acid diethylamide as an analgesic agent in patients with terminal illnesses

Das, S., & Maiti, T. | PAIN MANAGEMENT | 19 December 2019

By OPEN|2020-03-02T19:53:07+02:0019 December 2019|Tags: S. Das, T. Maiti|

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.

Family, N., Maillet, E. L., Williams, L. T., Krediet, E., Carhart-Harris, R. L., Williams, T. M., ... & Raz, S. | Psychopharmacology | 18 December 2019

By OPEN|2020-01-07T14:05:34+02:0018 December 2019|Tags: E. Krediet, E. Maillet, L. Williams, N. Family, R. Carhart-Harris|

Decreased directed functional connectivity in the psychedelic state.

Barnett, L., Muthukumaraswamy, S. D., Carhart-Harris, R. L., & Seth, A. K. | NeuroImage | 17 December 2019

By OPEN|2020-01-16T15:53:50+02:0017 December 2019|Tags: A. Seth, L. Barnett, R. Carhart-Harris, S. Muthukumaraswamy|